Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
about
Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significanceProfile of ramucirumab in the treatment of metastatic non-small-cell lung cancerRecurrence of Epithelioid Hemangioendothelioma during Pregnancy: Case Report and Systematic ReviewCharacteristics of tertiary lymphoid structures in primary cancersTumor suppressors and cell-cycle proteins in lung cancerTissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancerRole of tumor suppressor and angiogenesis markers in prediction of recurrence of non muscle invasive bladder cancer.Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells.Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma.Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survivalBlood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysisSuppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1.Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer.Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.Relationship between vascular invasion and microvessel density and micrometastasis.Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancerPrognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumorsPrognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers.Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancerReview of the effects of anti-angiogenic compounds on the epiphyseal growth plate.Identification of genes down-regulated during lung cancer progression: a cDNA array studyExpression of brain-specific angiogenesis inhibitor 1 is inversely correlated with pathological grade, angiogenesis and peritumoral brain edema in human astrocytomas.Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy.Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.Pazopanib: therapeutic developments.Prognostic and predictive factors in resected non-small-cell lung cancer.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro.Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study.Detailed assessment of microvasculature markers in non-small cell lung cancer reveals potentially clinically relevant characteristics.A Comparative Animal Study of Tendon Grafts Healing After Remnant-Preserving Versus Conventional Anterior Cruciate Ligament Reconstruction.Multiparametric PET/CT-perfusion does not add significant additional information for initial staging in lung cancer compared with standard PET/CT.Overexpression of endoglin (CD105) is associated with recurrence in radically resected gastric cancer.Lymphangiogenesis in non-Hodgkin's lymphoma and its correlation with cyclooxygenase-2 and vascular endothelial growth factor-C.ROS-cleavable proline oligomer crosslinking of polycaprolactone for pro-angiogenic host response
P2860
Q24813132-154BDA8D-6649-45CD-8993-A5213A1C6842Q26750715-C78B9868-925D-47FB-9B79-5314C552AC49Q26825594-C3E7AB1E-FE26-480B-8245-6035058A7C1EQ27012852-1AA504D1-4D92-43AE-B433-0A83BE9DD69EQ28392478-5F526DD9-09B1-4222-998D-EC7FCC7EE239Q33466556-9E9C2EA8-10F5-439C-9D5C-7C6D7AE2C118Q33613716-FA21A75C-036D-4A60-B0A6-8908D1AF700DQ33618841-06D6A287-249E-4060-91E5-3502B872EEAEQ33921567-DC76B7E1-B81E-4EF9-80CA-DCFFE5318588Q34026328-F54C2849-F701-425B-9168-FB493EF85164Q34110425-C062AAB1-9D61-4506-ADCC-7FEBCCA422F2Q34278743-70B80C15-7BCF-430D-8B76-E5CC4E62FE21Q34336386-4F3F6F3C-507C-4C1E-9842-927FC8EB3884Q34484134-995E63D1-8D73-4452-A51B-F0AC4D32A34BQ34723168-E83BBEF1-E9FF-4AC8-8183-136203EFF37AQ35132045-838A9C5D-2621-4EF8-B177-4035F08F1D48Q35177011-08E91BBD-70D6-45CF-BCF5-310F83D3C369Q35664735-EB8EBC1C-98E0-4D2C-9799-548A97AF692CQ36244067-F59AA390-4285-452E-A84F-917B794383DFQ36285676-1A4BC0E5-0320-4333-9B0A-7E06D5DD1A5DQ36296482-AF295321-8B34-4278-A2AB-BB299E70D2FBQ36421314-E14300FB-FF7F-4B36-8EAE-1D5ABAC3815AQ36916002-16B262CA-5B27-4DD1-9294-92E042B7FE2AQ36918765-AF8AA4E6-728E-4BE0-9884-B9B4436695F9Q36920386-64189778-2333-4821-BAAD-5F823A70A498Q37010405-2810686C-F8B3-42DB-BA62-3C87DD127C46Q37109977-C57DAB8D-B330-4832-BFAF-C9D24B891269Q37302424-B9131AF3-7926-485A-BCE1-3EF4DCA16C53Q37642770-A3859AA4-9FA5-496C-A1A0-E6799FA64D06Q38089884-F4FCACF2-12B7-486B-A814-1675220BB4E8Q38810926-7EC7B9AD-90E7-4FFE-8052-3353D3C2EEC2Q38817931-F671D6D5-ED4F-4EF7-AD0D-E5EEA84BDED3Q39693900-6964B4D1-2FB9-4ED4-9D55-BEFE114A0EF0Q40005099-F7C9CF11-9434-48EC-8C3E-6469B5F1E911Q41099763-AF2EBC84-2054-46A9-9E4E-98594DFF711AQ41226615-E405077D-4C65-45F1-936E-F5FB2EB186CAQ41890760-F5107D06-0496-426A-938F-1FA43D29B31EQ41970114-6FC9941F-143A-438E-B598-8B19169E7E8BQ42160346-C7767CEF-57C7-4E7C-AD39-F5612C7DC624Q42548783-59BF3D16-9539-4A2E-BB2C-9387A438AD87
P2860
Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prognostic impact of VEGF, CD3 ...... IA non-small cell lung cancer.
@ast
Prognostic impact of VEGF, CD3 ...... IA non-small cell lung cancer.
@en
type
label
Prognostic impact of VEGF, CD3 ...... IA non-small cell lung cancer.
@ast
Prognostic impact of VEGF, CD3 ...... IA non-small cell lung cancer.
@en
prefLabel
Prognostic impact of VEGF, CD3 ...... IA non-small cell lung cancer.
@ast
Prognostic impact of VEGF, CD3 ...... IA non-small cell lung cancer.
@en
P2093
P2860
P50
P356
P1476
Prognostic impact of VEGF, CD3 ...... IA non-small cell lung cancer.
@en
P2093
P2860
P304
P356
10.1136/JCP.2003.013508
P407
P577
2004-06-01T00:00:00Z